Roundup litigation centers on allegations that glyphosate, the active ingredient in this widely-used herbicide, is linked to Non-Hodgkin’s Lymphoma (NHL). Plaintiffs contend that Monsanto (now Bayer) failed to properly warn consumers of the potential cancer risks despite long-term use of Roundup. With substantial verdicts already delivered, this litigation remains a significant focus for firms managing mass tort claims involving agricultural workers and homeowners exposed to the product over prolonged periods.

Talcum powder litigation primarily targets manufacturers like Johnson & Johnson, with plaintiffs alleging that talc-based products contained asbestos, which led to ovarian cancer and mesothelioma. Mass tort attorneys are deeply involved in handling claims from long-term users of talc-based products, many of whom are battling life-threatening cancers. As multi-billion-dollar settlements have already materialized, this remains a critical area for firms engaged in high-profile, high-value cases.

This litigation targets manufacturers of chemical hair straighteners and relaxers, which plaintiffs claim are linked to an increased risk of uterine and ovarian cancers. The cases predominantly involve women, particularly women of color, who used these products over extended periods. Attorneys specializing in product liability and toxic exposure claims will find this emerging litigation of high interest, especially with new scientific studies confirming the carcinogenic risks.

PFAS (Per- and Polyfluoroalkyl Substances) are a class of “forever chemicals” linked to cancer, liver damage, and a host of other serious health conditions. Lawsuits focus on manufacturers like 3M and DuPont, accusing them of contaminating water supplies through industrial processes. PFAS litigation is expanding as both individual and class action claims grow. For firms focused on environmental and toxic tort cases, PFAS is a central and fast-developing mass tort.

The Bard PowerPort, an implantable device used for delivering medication, is the subject of litigation due to claims that defects in the device lead to infections, blood clots, and device failures. Plaintiffs allege Bard failed to provide adequate warnings regarding the risks, leading to serious injuries or death. This litigation is particularly important for firms specializing in medical device failures, as more cases are expected to emerge.